The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.
Michael HaudeStephen W L LeeStephen G WorthleySigmund SilberStefan VerheyeMohd A RosliRoberto BotelhoKui H SimAlexandre AbizaidRoxana Mehrannull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
At 5-year follow-up, the Combo stent remained clinically safe and effective with an overall low rate of MACE comparable to Taxus.